Literature DB >> 6309784

Type Ic, a novel glycogenosis. Underlying mechanism.

R C Nordlie, K A Sukalski, J M Muñoz, J J Baldwin.   

Abstract

The availability of a fresh, unfrozen liver biopsy specimen permitted the characterization of a unique type of glycogen storage disease. The subject, an 11-year-old female, showed the classic clinical symptoms of type I glycogenosis. However, her hepatic D-glucose-6-phosphate phosphohydrolase (EC 3.1.3.9) level as determined with detergent-activated homogenate was normal. The underlying mechanism was studied with intact microsomes from this fresh liver homogenate. Glucose-6-P phosphohydrolase was 75% latent, compared with 25% in normal controls matched for age and sex. Inorganic pyrophosphatase, PPi:glucose phosphotransferase, and carbamyl-P:glucose phosphotransferase activities of glucose 6-phosphatase were totally latent. While not observed with intact microsomes, these activities were fully manifested with detergent-disrupted microsomes. D-Glucose inhibited glucose-6-P phosphohydrolase activity of both intact and disrupted microsomes, but exogenous Pi inhibited only with the detergent-disrupted preparation. These observations are interpreted on the basis of the multicomponent glucose 6-phosphatase system of Arion et al. (Arion, W. J., Lange, A. J., Walls, H. E., and Ballas, L. M. (1980) J. Biol. Chem. 255, 10396-10406). All are consistent with a defect in T2, the putative translocase specific for Pi, PPi, and carbamyl-P. However, Pi produced endogenously from glucose-6-P hydrolysis within the microsomal lumen did not inhibit. This suggests that (i) a pathway for egress of Pi from the microsomal lumen exists independently of T2, (ii) T2 in this case works only unidirectionally, or (iii) the catalytic unit of glucose 6-phosphatase in situ has become desensitized to interactions with Pi, PPi, and carbamyl-P in this mutant model. Defects in both T1, the translocase specific for glucose-6-P, and T2 thus appear involved in this unique glycogenosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309784

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Therapeutic insulin and hepatic glucose-6-phosphatase activity in preterm infants.

Authors:  A Burchell; A McGeechan; R Hume
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

2.  Analysis of human hepatic microsomal glucose-6-phosphatase in clinical conditions where the T2 pyrophosphate/phosphate transport protein is absent.

Authors:  R C Nordlie; H M Scott; I D Waddell; R Hume; A Burchell
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

3.  Liver glucose-6-phosphatase activity and blood fatty acid level in rats with insulin-induced hypoglycemia.

Authors:  A D Nozdrachev; P K Telushkin
Journal:  Dokl Biol Sci       Date:  2008 Sep-Oct

4.  Transverse topology of glucose-6-phosphatase in rat hepatic endoplasmic reticulum.

Authors:  I D Waddell; A Burchell
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

5.  Diagnosis of glycogen storage disease.

Authors:  Y S Shin
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

6.  Stabilization of glucose-6-phosphatase activity by a 21 000-dalton hepatic microsomal protein.

Authors:  A Burchell; B Burchell; M Monaco; H E Walls; W J Arion
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

7.  The gene for glycogen-storage disease type 1b maps to chromosome 11q23.

Authors:  B Annabi; H Hiraiwa; B C Mansfield; K J Lei; T Ubagai; M H Polymeropoulos; S W Moses; R Parvari; E Hershkovitz; H Mandel; M Fryman; J Y Chou
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

8.  A method for the diagnosis of glycogen storage disease type Ib using polymorphonuclear leukocytes.

Authors:  N Bashan; R Potashnik; M Phillip; Y S Shin; S W Moses
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

9.  Specific inactivation of the phosphohydrolase component of the hepatic microsomal glucose-6-phosphatase system by diethyl pyrocarbonate.

Authors:  W J Arion; B Burchell; A Burchell
Journal:  Biochem J       Date:  1984-06-15       Impact factor: 3.857

10.  Glycogen storage disease type I in Tunisia: an epidemiological analysis.

Authors:  A Ben Chehida; N Tebib; W Cherif; H Ben Turkia; S Abdelmoula; H Azzouz; M F Ben Dridi
Journal:  J Inherit Metab Dis       Date:  2008-08-05       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.